Nohé B, Ploppa A, Schmidt V, Unertl K
Klinik für Anaesthesiologie und Intensivmedizin, Universitätsklinikum Tübingen, Deutschland.
Anaesthesist. 2011 May;60(5):457-64, 466-73. doi: 10.1007/s00101-011-1860-9.
Volume substitution represents an essential component of intensive care medicine. The amount of fluid administered, the composition and the timing of volume replacement seem to affect the morbidity and mortality of critically ill patients. Although restrictive volume strategies bear the risk of tissue hypoperfusion and tissue hypoxia in hemodynamically unstable patients liberal strategies favour the development of avoidable hypervolemia with edema and resultant organ dysfunction. However, neither strategy has shown a consistent benefit. In order to account for the heavily varying oxygen demand of critically ill patients, a goal-directed, demand-adapted volume strategy is proposed. Using this strategy, volume replacement should be aligned to the need to restore tissue perfusion and the evidence of volume responsiveness. As the efficiency of volume resuscitation for correction of tissue hypoxia is time-dependent, preload optimization should be completed in the very first hours. Whether colloids or crystalloids are more suitable for this purpose is still controversially discussed. Nevertheless, a temporally limited use of colloids during the initial stage of tissue hypoperfusion appears to represent a strategy which uses the greater volume effect during hypovolemia while minimizing the risks for adverse reactions.
容量替代是重症医学的一个重要组成部分。补液量、补液成分及补液时机似乎会影响危重症患者的发病率和死亡率。尽管限制性容量策略在血流动力学不稳定的患者中存在组织灌注不足和组织缺氧的风险,但宽松策略则有利于发生可避免的高血容量伴水肿及由此导致的器官功能障碍。然而,两种策略均未显示出持续的益处。为了满足危重症患者差异极大的氧需求,提出了一种目标导向、按需调整的容量策略。采用该策略时,补液应与恢复组织灌注的需求及容量反应性的证据相匹配。由于容量复苏纠正组织缺氧的效果具有时间依赖性,应在最初数小时内完成前负荷优化。胶体液和晶体液哪种更适合此目的仍存在争议。尽管如此,在组织灌注不足的初始阶段限时使用胶体液似乎是一种既能在低血容量时利用其更大的容量效应,又能将不良反应风险降至最低的策略。